Clinical Indication ID & Name
Bladder Cancer
Test Group
Solid Tumours (Adult)
Specialties
Test code
M217.1
Test name
Multi-target NGS panel - small variant (FGFR3, FGFR2)
Target genes
FGFR3, FGFR2
Test scope
Small variant detection
Test method/ technology
Panel
Optimal Family Structure
n/a
Eligibility Criteria
Patients for whom platinum chemotherapy and subsequent bladder sparing surgery are appropriate management options
Test code
M217.2
Test name
Multi-target NGS panel - copy number variant (FGFR3, FGFR2)
Target genes
FGFR3, FGFR2
Test scope
Copy number variant detection to exon level resolution
Test method/ technology
Panel
Optimal Family Structure
n/a
Eligibility Criteria
Patients for whom platinum chemotherapy and subsequent bladder sparing surgery are appropriate management options
Test code
M217.3
Test name
Multi-target NGS panel - structural variant (FGFR3, FGFR2, NTRK1, NTRK2, NTRK3)
Target genes
FGFR3, FGFR2, NTRK1, NTRK2, NTRK3
Test scope
Structural variant detection
Test method/ technology
Panel
Optimal Family Structure
n/a
Eligibility Criteria
Patients for whom platinum chemotherapy and subsequent bladder sparing surgery are appropriate management options
Commissioning group
n/a
Overlapping idications
n/a
Address for samples/request forms
North Thames GLH, Rare & Inherited Disease Genomic Laboratory
Specimen Reception, Level 5 Barclay House, 37 Queen Square,
London WC1N 3BH
Contact with queries
Supporting documents
Cancer WGS Clinician pack
Education resources
n/a
Service updates
n/a
Request form download
Consent record
See consent guidance in test request form
Sample requirements
See sample guidance in test request form